Tertiary lymphoid tissue in early-stage IgG4-related tubulointerstitial nephritis incidentally detected with a tumor lesion of the ureteropelvic junction: a case report.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
19 01 2021
Historique:
received: 08 06 2020
accepted: 12 01 2021
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 15 12 2021
Statut: epublish

Résumé

IgG4-related kidney disease causes renal impairment of unknown pathogenesis that may progress to kidney failure. Although ectopic germinal centers contribute to the pathogenesis of the head and neck lesions of IgG4-related disease, the presence of tertiary lymphoid tissue (TLT) containing germinal centers in IgG4-RKD has rarely been reported. We report a 72-year-old Japanese man who had IgG4-related tubulointerstitial nephritis (TIN) with TLT formation incidentally detected in a resected kidney with mass lesion of IgG4-related ureteritis in the ureteropelvic junction. During follow-up for past surgical resection of a bladder tumor, renal dysfunction developed and a ureter mass was found in the right ureteropelvic junction, which was treated by nephroureterectomy after chemotherapy. Pathology revealed no malignancy but abundant IgG4-positive cell infiltration, obliterative phlebitis and storiform fibrosis, confirming the diagnosis of IgG4-related ureteritis. In the resected right kidney, lymphoplasmacytes infiltrated the interstitium with focal distribution in the renal subcapsule and around medium vessels without storiform fibrosis, suggesting the very early stage of IgG4-TIN. Lymphocyte aggregates were also detected at these sites and consisted of B, T, and follicular dendritic cells, indicating TLT formation. IgG4-positive cells infiltrated around TLTs. Our case suggests that TLT formation is related with the development of IgG4-TIN and our analysis of distribution of TLT have possibility to elucidate IgG4-TIN pathophysiology.

Sections du résumé

BACKGROUND
IgG4-related kidney disease causes renal impairment of unknown pathogenesis that may progress to kidney failure. Although ectopic germinal centers contribute to the pathogenesis of the head and neck lesions of IgG4-related disease, the presence of tertiary lymphoid tissue (TLT) containing germinal centers in IgG4-RKD has rarely been reported.
CASE PRESENTATION
We report a 72-year-old Japanese man who had IgG4-related tubulointerstitial nephritis (TIN) with TLT formation incidentally detected in a resected kidney with mass lesion of IgG4-related ureteritis in the ureteropelvic junction. During follow-up for past surgical resection of a bladder tumor, renal dysfunction developed and a ureter mass was found in the right ureteropelvic junction, which was treated by nephroureterectomy after chemotherapy. Pathology revealed no malignancy but abundant IgG4-positive cell infiltration, obliterative phlebitis and storiform fibrosis, confirming the diagnosis of IgG4-related ureteritis. In the resected right kidney, lymphoplasmacytes infiltrated the interstitium with focal distribution in the renal subcapsule and around medium vessels without storiform fibrosis, suggesting the very early stage of IgG4-TIN. Lymphocyte aggregates were also detected at these sites and consisted of B, T, and follicular dendritic cells, indicating TLT formation. IgG4-positive cells infiltrated around TLTs.
CONCLUSIONS
Our case suggests that TLT formation is related with the development of IgG4-TIN and our analysis of distribution of TLT have possibility to elucidate IgG4-TIN pathophysiology.

Identifiants

pubmed: 33468063
doi: 10.1186/s12882-021-02240-1
pii: 10.1186/s12882-021-02240-1
pmc: PMC7816437
doi:

Substances chimiques

Immunoglobulin G 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

34

Références

Nephrol Dial Transplant. 2012 Jul;27(7):2755-61
pubmed: 22228836
Biomed Res. 2015;36(2):143-53
pubmed: 25876665
Medicine (Baltimore). 2012 Jan;91(1):49-56
pubmed: 22198501
Kidney Int. 2013 Oct;84(4):826-33
pubmed: 23698232
Clin Exp Nephrol. 2011 Oct;15(5):615-626
pubmed: 21898030
J Immunol. 2010 Jul 1;185(1):717-28
pubmed: 20525884
Intern Med. 2015;54(10):1253-7
pubmed: 25986266
J Clin Invest. 2014 Mar;124(3):953-9
pubmed: 24590281
Mod Rheumatol. 2016 Nov;26(6):923-928
pubmed: 26943245
Ann Rheum Dis. 2019 Mar;78(3):406-412
pubmed: 30612117
Nat Rev Immunol. 2010 Sep;10(9):664-74
pubmed: 20706277
Clin Kidney J. 2012 Jun;5(3):225-8
pubmed: 26069770
Ann Rheum Dis. 2012 Dec;71(12):2011-19
pubmed: 22753386
Front Immunol. 2018 Sep 12;9:1952
pubmed: 30258435
JCI Insight. 2016 Jul 21;1(11):e87680
pubmed: 27699223
Arthritis Res Ther. 2016 Nov 25;18(1):273
pubmed: 27884179
Mod Pathol. 2018 Jun;31(6):890-899
pubmed: 29434340
Mod Rheumatol. 2018 Jan;28(1):188-192
pubmed: 26381653
Front Physiol. 2019 Mar 14;10:251
pubmed: 30923503
Am J Surg Pathol. 2010 Dec;34(12):1812-9
pubmed: 21107087
Hum Pathol. 2016 Sep;55:164-73
pubmed: 27246178
Hum Pathol. 2012 Apr;43(4):536-49
pubmed: 21889187
Ann Vasc Dis. 2019 Dec 25;12(4):460-472
pubmed: 31942203
Clin Immunol. 2019 Jan;198:1-10
pubmed: 30419354
Kidney Int. 2020 Aug;98(2):448-463
pubmed: 32473779
Mod Rheumatol. 2019 Mar;29(2):231-239
pubmed: 30499730
Clin J Am Soc Nephrol. 2014 Feb;9(2):255-64
pubmed: 24262509
Trends Immunol. 2012 Jun;33(6):297-305
pubmed: 22622061
Rheumatology (Oxford). 2018 Feb 1;57(2):236-245
pubmed: 28460058

Auteurs

Tatsuhito Miyanaga (T)

Division of Rheumatology, Department of Internal Medicine, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.

Keishi Mizuguchi (K)

Department of Diagnostic Pathology, Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.

Satoshi Hara (S)

Division of Rheumatology, Department of Internal Medicine, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan. satoshihara@staff.kanazawa-u.ac.jp.

Takeshi Zoshima (T)

Division of Rheumatology, Department of Internal Medicine, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.

Dai Inoue (D)

Department of Radiology, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.

Ryo Nishioka (R)

Division of Rheumatology, Department of Internal Medicine, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.

Ichiro Mizushima (I)

Division of Rheumatology, Department of Internal Medicine, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.

Kiyoaki Ito (K)

Division of Rheumatology, Department of Internal Medicine, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.

Hiroshi Fuji (H)

Division of Rheumatology, Department of Internal Medicine, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.

Kazunori Yamada (K)

Department of Hematology and Immunology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku, Ishikawa, Japan.

Yuki Sato (Y)

Department of Nephrology, Kyoto University Graduate School of Medicine, Yoshidakonoe-cho, Sakyo-ku, Kyoto, Japan.
Medical Innovation Center TMK Project, Graduate School of Medicine, Kyoto University, 53 Shogoin, Kawahara-cho, Sakyo-ku, Kyoto, Japan.

Motoko Yanagita (M)

Medical Innovation Center TMK Project, Graduate School of Medicine, Kyoto University, 53 Shogoin, Kawahara-cho, Sakyo-ku, Kyoto, Japan.
Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-honmachi, Sakyo-ku, Kyoto, Japan.

Mitsuhiro Kawano (M)

Division of Rheumatology, Department of Internal Medicine, 13-1 Takaramachi, Kanazawa, Ishikawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH